No fees unless we win.
Get a free consultation
A study in the British Medical Journal reported recently that pregnant women who take antidepressants like Zoloft close to their delivery dates are at an increased risk for postpartum hemorrhaging.
The study focused specifically on antidepressants or selective serotonin reuptake inhibitors (SSRIs) including Zoloft, Paxil and Prozac. The authors of the study found that postpartum hemorrhaging in women has increased in the United States from 2.3 percent in the early 1990s, to 2.9 percent between 1994 and 2006.
It should be noted that postpartum hemorrhaging is the leading cause of maternal mortality in the country. Aside from death, it can lead to blood transfusions and admission into intensive care treatment.
The authors note that between the periods when hemorrhaging increased, 7 to 13 percent of pregnant women in the United States were treated with antidepressants. The authors suggested that the use of SSRIs at the time of delivery could increase the risk of hemorrhaging complications.
The study itself focused on 106,000 pregnant women between the ages of 12 and 55 who were placed into four groups based on the last time they took an SSRI. The groups included women who were taking the drugs, those who had taken them in the last 30 days, those who had taken them in the past 1 to 5 months and those who did not take them.
The study found that women who did not take SSRIs experienced a 3.8 percent risk of hemorrhaging complications during birth, while those who were on SSRIs at the time of delivery experienced a 4 percent risk of bleeding complications.
Aside from hemorrhaging, SSRI pregnancy complications can include birth defects like cleft lip and palate, persistent pulmonary hypertension of the newborn (PPHN), septal heart defects and craniosynostosis.
If you would like more information about SSRIs, please feel free to contact us toll-free (888)841-9623 or submit your inquiry online.
ZOLL, KRANZ & BORGESS, LLC –Legal advocates for medical drug/device safety & effectiveness
Michelle is a founding partner of Zoll & Kranz, located in Toledo, Ohio. Michelle has been a plaintiff’s lawyer for the entirety of her practice – over 32 years. She devotes the majority of her time to complex consolidated litigation and class action including advocating for people injured by medical devices, prescription medications, or corporate negligence.
This article has been written and reviewed for legal accuracy and clarity by the team of writers and attorneys at Zoll & Kranz, LLC and is as accurate as possible. This content should not be taken as legal advice from an attorney. If you would like to learn more about our owner and experienced Ohio injury lawyer, Michelle L. Kranz, you can do so here.
Zoll & Kranz, LLC does everything possible to make sure the information in this article is up to date and accurate. If you need specific legal advice about your case, contact us. This article should not be taken as advice from an attorney.
A serious injury can have life-altering results.
Don’t settle for less than you deserve, speak with an award-winning personal injury lawyer today.
FDA Warns Pfizer’s Drug Tygacil Raises Risk of Death
FDA Announces da Vinci Surgical System Robot Recall
FDA Issues Warning Over Phillips Heart Defibrillators
FDA Issues Warning About Medtronic Guidewire Recall
Unsterile Medical Device Recall: Zoll & Kranz, LLC is investigating the Seprafilm Class II Recall
For over 37 years, Zoll & Kranz has been fighting for clients who have been the victims of the wrongful death of a loved one.
Do you believe you’re entitled to compensation?
Use our Instant Case Evaluator to find out in as little as 60 seconds!
A serious injury can have life-altering results.
Don’t settle for less than you deserve, speak with an award-winning personal injury lawyer today.
